Despite omega-3s reaching the brain, no cognitive benefit was found. A two-year USC clinical trial of 365 older adults at Alzheimer's risk found that high-dose fish oil supplements — even when DHA levels in the brain measurably increased — did not improve memory, cognitive function, or prevent hippocampal shrinkage compared to placebo. Researchers say a healthy lifestyle remains the best defense against cognitive decline.
Americans spend over $1 billion a year on omega-3 fish oil supplements hoping to preserve brain health — but a new two-year clinical trial from Keck Medicine of USC suggests those hopes may be misplaced. Published in eBioMedicine, the study found that high-dose DHA supplements provided no measurable cognitive benefit to older adults at elevated Alzheimer's risk, even when the omega-3s successfully reached the brain.
The trial enrolled 365 adults aged 55–80 who rarely ate fish and were at increased Alzheimer's risk. Participants received either 2,000 mg of DHA daily or a placebo. After six months, cerebrospinal fluid DHA levels rose 17% in the supplement group — confirming brain uptake — yet after two years, cognitive test scores and hippocampal volume showed no meaningful difference between groups.
By the Numbers:
Why it matters: These findings challenge a widely held belief and suggest that isolated high-dose supplementation works differently than omega-3s consumed through a balanced diet. Researchers now suspect that overall health, genetics, and dietary patterns influence how the brain uses these nutrients — and are exploring whether future medications could help the brain utilize omega-3s more effectively. For now, regular exercise, quality sleep, and a balanced diet remain the most evidence-backed tools for Alzheimer's prevention.
